TOP TIERMARKET NEWSWIRE
News & sentiment

TRAVERE THERAPEUTICS (TVTX) — News & AI sentiment

TRAVERE THERAPEUTICS (TVTX) news roundup. 2 stories in the past week, 4 over 30 days. Average 30-day sentiment is 58.5/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 5 sales totalling $2.7M — net selling of $2.7M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 54/100
30d stories
4
avg sentiment 58.5/100
Insider net (90d)
$2.7M
0 buys · 5 sells
Congress (90d)
0
0 buys · 0 sells

TVTX news in the last 24 hours, 7 days, 30 days and 90 days

How much TVTX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowTVTX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days254/100TVTX headlines →
Last 30 days458.5/100TVTX headlines →
Last 90 days2954.9/100TVTX headlines →

Latest stories on TVTX

2d ago
5d ago
Aug 21
Travere Therapeutics: Valuation Suggests A Buy
Seeking Alpha63 · neutralanalyst
Aug 19
Aug 12
Aug 11
Aug 10
Aug 6
Aug 6
Aug 6
Aug 5
Stifel raises Travere Therapeutics price target on FSGS launch
Investing.com Analyst Ratings61 · neutralanalyst
Aug 5
Aug 5
Aug 5
At a glance: stocks gapping up premarket
Seeking Alpha63 · neutralgeneral
Aug 5
Aug 5
Aug 5
Aug 4
Aug 4
Travere Therapeutics Q2 2026 Earnings Preview
Seeking Alpha55 · neutralearnings
Aug 3
Jul 28
Jul 27
Jul 10
Jul 9
Jul 9
Open TVTX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →